South Korea's Penetrium Bioscience unveiled a novel approach to cancer treatment that targets the environments surrounding ...
New data highlight predictive patient-derived models, resistance insights, and end-to-end translational workflows to improve translational oncology confidence ...
Penetrium Bioscience (KOSDAQ 187660) today announced compelling new scientific evidence demonstrating, for the first time at ...
Panome Bio, a leading multi-omics contract research organization (CRO) and CLIA-certified laboratory, today announced a ...
Niagen Bioscience is transitioning from supplements to a telehealth-driven longevity platform, targeting higher margins and ...
On December 2, the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations, of which NH Life Sciences is a member, released a new report, “The U.S. Bioscience ...
More than 100 Butler County leaders, school officials, teachers and high school students saw the official opening ceremony ...
Kivu Bioscience, a clinical-stage biotechnology company developing next-generation antibody-drug conjugates (ADCs) for ...
In a recent interview, Robert Fried, CEO of Niagen Bioscience, delves into the science of aging and the pivotal role of a molecule known as NAD (nicotinamide adenine dinucleotide). He explains how NAD ...
A new Bend-based bioscience lab could become operational as early as December of this year, with manufacturing and analytical capabilities coming online in mid-2023. Earlier this month, the ...
Margaret R. McLean delivered this address to the Keck Graduate Institute Convocation in September 2010. She is associate director of the Markkula Center for Applied Ethics and Director of Bioethics.
View Lexaria Bioscience Corp. LEXX stock quote prices, financial information, real-time forecasts, and company news from CNN.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results